- Tytuł:
- Randomised, phase II, placebo-controlled, trial of fulvestrant plus vandetanib in postmenopausal women with bone only or bone predominant, hormone-receptor-positive metastatic breast cancer (MBC): the OCOG ZAMBONEY study
- Autorzy:
- Źródło:
-
Breast Cancer Research and Treatment . July 2014 146(1):153-162
Czasopismo naukowe